The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...